NP / PA
Tobias, Lorena
Tobias, Lorena was paid $219K by Medicaid between Jan 2018 and Nov 2024, across 35 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 40% of everything it billed.
33Billing provider infoTOBIAS, LORENA
BRONX, NY 10453
BRONX, NY 10453
33aNPI1730561374assigned 06/19/2015
33bProvider typePediatric Nurse Practitioner
28Total paid$219K
24GClaims7,465
24DCodes billed35
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Pediatric Nurse Practitioner providers in New York
Rank by total paid#5 of 91
Median peer was paid$2K
This provider vs. median101×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 2,340 | $77K | |
| 2019 | 1,302 | $55K | |
| 2020 | 468 | $18K | |
| 2023 | 1,505 | $27K | |
| 2024incomplete | 1,850 | $43K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 40% | 1,670 | 1,479 | $88K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 19% | 609 | 551 | $41K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 10% | 588 | 553 | $22K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 9.1% | 328 | 323 | $20K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 6.6% | 226 | 223 | $15K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 2.7% | 445 | 436 | $6K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 2.1% | 78 | 74 | $5K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 1.8% | 41 | 39 | $4K |
| 90756 | 1.7% | 241 | 236 | $4K | |
| 99401 | 1.6% | 176 | 169 | $4K | |
| 99442 | 1.4% | 61 | 59 | $3K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 81 | 80 | $2K |
23 more codes
| S9452 | Nutrition classes, non-physician provider, per session | <1% | 259 | $1K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 234 | $1K |
| 90461 | <1% | 48 | $1K | |
| 99384 | <1% | 17 | $1K | |
| 99383 | <1% | 21 | $785.92 | |
| 99382 | <1% | 15 | $634.16 | |
| 92551 | <1% | 52 | $385.36 | |
| 98960 | <1% | 128 | $323.75 | |
| T1013 | Sign language or oral interpretive services, per 15 minutes | <1% | 15 | $122.72 |
| 99051 | <1% | 142 | $84.00 | |
| V5008 | Hearing screening | <1% | 534 | $25.00 |
| 90658 | <1% | 36 | $11.37 | |
| 99173 | <1% | 379 | $9.26 | |
| 1125F | 0% | 21 | $0.00 | |
| 94760 | 0% | 68 | $0.00 | |
| 90686 | 0% | 71 | $0.00 | |
| 2010F | 0% | 393 | $0.00 | |
| 36415 | Collection of venous blood by venipuncture | 0% | 16 | $0.00 |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 0% | 113 | $0.00 |
| 1126F | 0% | 219 | $0.00 | |
| 3725F | 0% | 115 | $0.00 | |
| 90734 | 0% | 13 | $0.00 | |
| 90633 | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.